GSK Ventures Into Device World With Bioelectronic Investment
This article was originally published in The Gray Sheet
Executive Summary
The British pharmaceutical maker has financed a new venture capital fund to create a presence in emerging bioelectronic technology and to help jumpstart the fledgling industry because it believes that the science has reached a transition point.